Article ; Online: Using the AS04C-adjuvanted hepatitis B vaccine in patients classified as non-responders.
Transactions of the Royal Society of Tropical Medicine and Hygiene
2023 Volume 118, Issue 3, Page(s) 170–177
Abstract: Background: Chronic hepatitis B (HB) remains a significant global health concern, despite the widespread availability of the HB vaccine. While the standard vaccine demonstrates an impressive serological response rate exceeding 90%, a subset of ... ...
Abstract | Background: Chronic hepatitis B (HB) remains a significant global health concern, despite the widespread availability of the HB vaccine. While the standard vaccine demonstrates an impressive serological response rate exceeding 90%, a subset of individuals exhibit suboptimal immunity. This study aims to elucidate the efficacy of the AS04C-adjuvanted HB vaccine in addressing non-responsiveness. Methods: Conducted at the Preventive Medicine Service of the University Albacete Hospital in Spain from 2017 to 2021, this single-center observational study enrolled 195 patients. Among them, 126 (65%) were classified as non-responders following one or two complete standard vaccination courses. Results: After the administration of a complete four-dose regimen of the AS04C-adjuvanted vaccine, 73.81% of non-responder patients exhibited antibody titers indicative of robust immunity (anti-HBs >10). Conclusions: These findings underscore the pivotal role of the AS04C-adjuvanted HB vaccine in addressing non-responsiveness, emphasizing its potential as a crucial tool in augmenting immunization strategies for various populations. This includes non-responders to standard vaccination, individuals with chronic kidney disease, those requiring seroprotection due to factors like immunosuppression or occupational hazards, as well as patients for whom conventional revaccination strategies have proven futile. Additional research is needed to expand on the promising results obtained through our protocol. |
---|---|
MeSH term(s) | Humans ; Hepatitis B Vaccines/therapeutic use ; Immunization, Secondary ; Vaccination/methods ; Hepatitis B Antibodies ; Renal Insufficiency, Chronic ; Hepatitis B/prevention & control |
Chemical Substances | Hepatitis B Vaccines ; Hepatitis B Antibodies |
Language | English |
Publishing date | 2023-10-15 |
Publishing country | England |
Document type | Observational Study ; Journal Article |
ZDB-ID | 441375-1 |
ISSN | 1878-3503 ; 0035-9203 |
ISSN (online) | 1878-3503 |
ISSN | 0035-9203 |
DOI | 10.1093/trstmh/trad078 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Un I Zs.257: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.